Implications of Complete Proteinuria Remission at any Time in Focal Segmental Glomerulosclerosis: Sparsentan DUET Trial

INTRODUCTION: Focal segmental glomerulosclerosis (FSGS) is a rare glomerular disease with high unmet clinical need. Interest in proteinuria as a surrogate end point for regulatory approval of novel treatments has increased. We assessed the relationship between achieving complete remission (CR) of pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Trachtman, Howard, Diva, Ulysses, Murphy, Edward, Wang, Kaijun, Inrig, Jula, Komers, Radko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577371/
https://www.ncbi.nlm.nih.gov/pubmed/37850006
http://dx.doi.org/10.1016/j.ekir.2023.07.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577371/
https://www.ncbi.nlm.nih.gov/pubmed/37850006
http://dx.doi.org/10.1016/j.ekir.2023.07.022

Ejemplares similares